首页 | 本学科首页   官方微博 | 高级检索  
     

抗甲状腺药的进展与应用评价
引用本文:田硕涵,周颖. 抗甲状腺药的进展与应用评价[J]. 中国医院用药评价与分析, 2008, 8(6): 410-411
作者姓名:田硕涵  周颖
作者单位:北京大学第一医院药剂科,北京市,100034
摘    要:目的:评价抗甲状腺药的疗效、不良反应和进展,以供临床用药参考。方法:通过查阅近期国内、外相关文献进行总结、分析。结果与结论:对于大多数病人,特别是甲状腺不太大、青少年、妊娠或哺乳期妇女的甲亢患者,抗甲状腺药是首选的主要治疗手段。在治疗前及治疗中应密切监测患者的肝、肾功能,白细胞总数及分类,以便及时发现异常情况,给予停药或相应处理。

关 键 词:抗甲状腺药  进展  临床应用

Progress and Clinical Evaluation of the Antithyroid Drugs
TIAN Shuo-han,ZHOU Ying. Progress and Clinical Evaluation of the Antithyroid Drugs[J]. Evaluation and Analysis of Drug-Use in Hospital of China, 2008, 8(6): 410-411
Authors:TIAN Shuo-han  ZHOU Ying
Affiliation:(Dept. of Pharmacy, The First Hospital of Peking University, Beijing 100034, China)
Abstract:OBJECTIVE: To evaluate the progress, clinical efficacy and adverse reactions of antithyroid drugs for references of clinical drug use. METHODS: Recent pertinent medical literature both at home and abroad was reviewed and analyzed. RESULT & CONCLUSION: For most patients with hyperthyreosis, especially those with small thyroid, adolescents, or women at pregnancy or lactation, antithyroid drugs are preferred. Function of liver and kidney, TWBC (total white blood cells ) and its differential count should be given close monitoring to withdraw drugs or give corresponding management in case of abnormalities.
Keywords:Antithyroid drugs  Progress  Clinical use
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号